i3 Health

https://i3health.com/

 

i3 Health
C

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast Cancer Therapies - CDK4/6 Inhibitors

By i3 Health FEATURING Constance Visovsky
By i3 Health FEATURING Constance Visovsky
0 views
December 30, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
ODACon
08:35
i3 Health

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

Feat. J. Metsker
07:59
i3 Health

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

Feat. J. Metsker
06:47
i3 Health

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

Feat. A. Kaler
07:57
i3 Health

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

Feat. J. Labarbera
07:25
i3 Health

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

Feat. C. Visovsky
07:41
i3 Health

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

Feat. J. Labarbera